{"schema_version":"secwatch.filing_event.v1","accession":"0001613103-22-000016","form_type":"8-K","ticker":"MDT","cik":"0001613103","company_name":"Medtronic plc","filed_at":"2022-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.486333+00:00","generated_at":"2026-06-25T06:47:35.138157+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Medtronic posts FY22 rev +5%, Q4 adj EPS +2%; hikes dividend 8%, forms kidney JV with DaVita","bullets":["FY22 revenue $31.686B, +5% reported and organic; Q4 revenue $8.1B, -1% reported, +1% organic.","Q4 GAAP diluted EPS $1.10 (+10%), non-GAAP diluted EPS $1.52 (+2%); FY22 GAAP diluted EPS $3.73 (+40%).","Quarterly dividend raised to $0.68 from $0.63 (+8%); annual $2.72; 45th consecutive year of increases.","Medtronic and DaVita form equally-owned kidney device JV; Medtronic contributes RCS ($325M FY22 rev). DaVita pays up to $400M value. Close expected calendar 2023.","FY23 guidance issued; no material adjusted EPS impact from JV in current or near-term fiscal years."],"urls":{"canonical":"https://secwatch.observer/filing/0001613103-22-000016","json":"https://secwatch.observer/filing/0001613103-22-000016.json","markdown":"https://secwatch.observer/filing/0001613103-22-000016.md","text":"https://secwatch.observer/filing/0001613103-22-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613103/000161310322000016/0001613103-22-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613103/000161310322000016/mdt-20220526.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T06:47:35.138157+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}